Interferon-gamma release assay: Difference between revisions

From IDWiki
(Created page with "* Test for diagnosis latent tuberculosis infection * Unclear utility in children under 5 years * Levels often decline after treatment for LTBI or active tuberculosis, but...")
 
No edit summary
Line 1: Line 1:
  +
== Background ==
* Test for diagnosis [[latent tuberculosis infection]]
 
  +
* ''In vitro'' test that assess for a cell-mediated immune response to [[tuberculosis]] antigens
  +
** Usually early secreted antigenic target 6 (ESAT-^) and culture filtrate protein 10 (CFP-10)
 
* Used for diagnosis [[latent tuberculosis infection]]
 
* Unclear utility in children under 5 years
 
* Unclear utility in children under 5 years
 
* Levels often decline after treatment for LTBI or active tuberculosis, but remain positive
 
* Levels often decline after treatment for LTBI or active tuberculosis, but remain positive
  +
* In Canada, we have two tests available:
*
 
  +
** QuantiFERON-TB Gold Plus (QFT-Plus): an in-tube ELISA whole-blood test of ESAT-6 and CFP-10, uses 2 tubes (the second designed to stimulate CD8 T-cells), and is reported in IU/mL
  +
** T-SPOT.''TB'': a spot ELISA assay performed on separated peripheral blood mononuclear cells, using ESAT-6 and CFP-10, and is reported in the number of spots compared to a control
  +
  +
== Interpretation ==
  +
  +
=== QuantiFERON-TB Gold Plus ===
  +
  +
* Reports the IU/mL of 4 tubes: negative control (which assesses baseline interferon activity), antigen 1, antigen 2, and mitogen control (to assess their immune response in general)
  +
* Reported as positive if either antigen 1 or 2 is ≥0.35 above the control tube
  +
  +
{| class="wikitable"
  +
! colspan="4" |Tube (IU/mL)
  +
! rowspan="2" |Result
  +
|-
  +
!Nil
  +
!TB1 - nil
  +
!TB2 - nil
  +
!Mitogen - nil
  +
|-
  +
| rowspan="4" |≤8
  +
|≥0.35 and ≥25% of nil
  +
|any
  +
| rowspan="2" |any
  +
| rowspan="2" |positive
  +
|-
  +
|any
  +
|≥0.35 and ≥25% of nil
  +
|-
  +
| rowspan="2" |<0.35, or ≥0.35 and <25% of nil
  +
| rowspan="2" |<0.35, or ≥0.35 and <25% of nil
  +
|≥0.5
  +
|negative
  +
|-
  +
|<0.5
  +
| rowspan="2" |indeterminate
  +
|-
  +
|>8
  +
| colspan="3" |any
  +
|}
  +
  +
=== T-SPOT.''TB'' ===
  +
  +
* Reports the number of spots in the antigen wells compared to a control well
  +
* Positive it at least 8 more spots in the antigen wells
  +
  +
=== False Positives ===
  +
  +
* The antigens cross-react with some species of [[non-tuberculous mycobacteria]], particularly [[Mycobacterium marinum]], [[Mycobacterium kansasii]], [[Mycobacterium szulgai]], and [[Mycobacterium flavescens]]
   
 
[[Category:Tuberculosis]]
 
[[Category:Tuberculosis]]

Revision as of 10:28, 15 April 2024

Background

  • In vitro test that assess for a cell-mediated immune response to tuberculosis antigens
    • Usually early secreted antigenic target 6 (ESAT-^) and culture filtrate protein 10 (CFP-10)
  • Used for diagnosis latent tuberculosis infection
  • Unclear utility in children under 5 years
  • Levels often decline after treatment for LTBI or active tuberculosis, but remain positive
  • In Canada, we have two tests available:
    • QuantiFERON-TB Gold Plus (QFT-Plus): an in-tube ELISA whole-blood test of ESAT-6 and CFP-10, uses 2 tubes (the second designed to stimulate CD8 T-cells), and is reported in IU/mL
    • T-SPOT.TB: a spot ELISA assay performed on separated peripheral blood mononuclear cells, using ESAT-6 and CFP-10, and is reported in the number of spots compared to a control

Interpretation

QuantiFERON-TB Gold Plus

  • Reports the IU/mL of 4 tubes: negative control (which assesses baseline interferon activity), antigen 1, antigen 2, and mitogen control (to assess their immune response in general)
  • Reported as positive if either antigen 1 or 2 is ≥0.35 above the control tube
Tube (IU/mL) Result
Nil TB1 - nil TB2 - nil Mitogen - nil
≤8 ≥0.35 and ≥25% of nil any any positive
any ≥0.35 and ≥25% of nil
<0.35, or ≥0.35 and <25% of nil <0.35, or ≥0.35 and <25% of nil ≥0.5 negative
<0.5 indeterminate
>8 any

T-SPOT.TB

  • Reports the number of spots in the antigen wells compared to a control well
  • Positive it at least 8 more spots in the antigen wells

False Positives

References

  1. ^  Jorge R. Ledesma, Jianing Ma, Peng Zheng, Jennifer M. Ross, Theo Vos, Hmwe H. Kyu. Interferon-gamma release assay levels and risk of progression to active tuberculosis: a systematic review and dose-response meta-regression analysis. BMC Infectious Diseases. 2021;21(1). doi:10.1186/s12879-021-06141-4.